Condition
Fear of Cancer
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05604365Not ApplicableCompleted
FearLess in Cognitively Intact Patients With Glioma
NCT03336827Not ApplicableCompleted
Improving Emotion Regulation at the End of Breast Cancer Treatment
NCT03763825Not ApplicableUnknown
Mini-AFTERc Intervention for Fear of Cancer Recurrence
NCT03384992Not ApplicableCompleted
Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors
Showing all 4 trials